Key facts
- It has raised $10K; the latest was Seed Round in Aug 2025.
- Notable investors include Plug and Play Tech Center, Startup Lithuania Accelerator powered by Plug and Play, AXOLOTL (Germany), Incate, Strascheg Center for Entrepreneurship — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Puray
- ·The full record, as it builds
Funding rounds
No funding rounds for Puray are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Puray
Developer of UV-C (Ultraviolet-C) light-enabled medical tubing designed to disinfect device-access pathways using photonic methods without harming tissue. The company offers medical-grade tubing with built-in light disinfection, antimicrobial protection, long-term use, and safety assurance, enabling healthcare providers to reduce device-associated infection risk, minimise antibiotic use, improve patient outcomes, and lower hospital-acquired infection costs.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2018
- Employees
- 6
- Website
- puray.de/
- Ownership
- Privately Held (backing)
Puray doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Puray shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Puray in its N-PORT filings yet. We sweep new filings monthly.